The newly established Center for Radiation Oncology Research (CROR) is one of eight component centers of the Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer. Our mission is to contribute to the elimination of cancer by improving radiation therapy through advancing the science of radiation therapy, optimizing the integration of radiotherapy into multidisciplinary patient careand educating trainees, professionals, and the public.
Advances in the precision of radiation planning and delivery technology, understanding of the molecular basis of cellular and tissue response to radiation, and use of biomarkers and biomedical imaging open unprecedented opportunities for research in radiation oncology. These advances have direct applicability to therapy with photons, electrons, protons and sealed isotopes (brachytherapy). The CROR provides the framework for aligning radiation oncology research into several programmatic themes that are applicable to all radiation therapy modalities and to provide the centralized infrastructure to facilitate research efforts.
The research themes of the CROR are grouped into three main branches: radiation technology; biological studies; and human health services.
H.R. Withers, M.D. and his team spent decades pursuing basic questions in radiation science to understand how a body responds to radiation damage. The work pursued by his team was recently collected, digitized and organized into the Withers' Archive, now publically available through CROR. The archive consists of several assays and tissue responses to various doses and schedules of radiation. The announcement regarding the availability of the Wither’s Archive was recently published by The Red Journal, The Green Journal, The Blue Journal and Radiation Research. For any questions regarding or requests for access to Wither’s Archive, please contact CRORadmin@mdanderson.org
In memory of Professor Raymond Meyn Jr.
It is with a heavy heart that we say goodbye to Raymond Meyn, Ph.D. after his long battle with cancer. Meyn has been invaluable to the success of CROR and a champion of radiation science. The resident radiation biology expert, he was the pillar of the institution, division, and the Center. Even after retiring, Meyn continued to be actively involved in research projects, departmental and laboratory meetings and grant applications, offering his extensive knowledge and wisdom to our research teams. Without him, a number of ongoing, funded, CROR-backed research projects would not have happened.
As a researcher, colleague, mentor, and teacher, Meyn generously shared his knowledge, experience, and insights. In many instances, these conversations with Meyn shaped, refined and transformed some of our own research endeavors. His approach to any and all scientific pursuits was to first examine the problem from every angle, a task he went about with child-like curiosity and a sparkle in his eye, then to learn everything he could about the issue at hand, a task he undertook with classical scholarly zeal, and finally to propose real-world practical solutions. Much like clay in the hands of a master potter, what often emerges from these conversations with Meyn is a work of art, verging on pure genius. We are forever indebted to him for his encouragement, passionate exhortation and relentless intellectual stimulation, and can only hope that the resulting research will do him proud.
Meyn’s academic achievements have few comparisons but it is revealing that he always listed as his proudest professional accomplishments bringing agents into clinical trials for radiosensitization. He was instrumental in acquiring preliminary data that led to human studies examining sunitinib and erlotinib in combination with radiotherapy for solid tumors. Even in the age of splashy science, Meyn never forgot the ultimate reason for our pursuit of radiation science research: to help patients in their battle against cancer. It is a motto that will continue to be the driving force for CROR investigators.
Sunil, Heath, & Alma
We would like to thank and acknowledge the CROR donors who make all of our work possible.
E.L. Wiegand Foundation and James B. and Lois R. Archer Foundation together made a donation to establish the CROR Shared Resource for Advanced Chemical Imaging. While the resource is run through CROR, it is available for use to the entire MD Anderson community. We thank both foundations for their generous gift.
E.L. Wiegand Foundation
James B. & Lois R. Archer Charitable Foundation
E.L. and Thelma Gaylord Foundation
Mr. and Mrs. William Dr. Rollnick
The Inflammatory Breast Cancer Advocacy and Research Foundation
Ann and Clarence P. Cazalot, Jr.
Young Texans Against Cancer - Houston Chapter
Mr. W Michael Carter
Georga and Judd Harrison
Mr. and Mrs. Hines
Zeta Tau Alpha Foundation, Inc.